2022 American Transplant Congress » Biomarkers: Clinical Outcomes II
Date: Tuesday, June 7, 2022
Time: 5:30pm-7:00pm
Location: Hynes Ballroom A
Session Type: Rapid Fire Oral Abstract
Meeting: 2022 American Transplant Congress
- 5:40pm-5:50pm
Development and Validation of an Integrative DD-CFDNA System to Predict Allograft Rejection: A Population Based Study
- 6:00pm-6:10pm
Enhanced Histological Yield and Actionable Findings When Biopsy is Guided by Donor-Derived Cell-Free DNA (dd-cfDNA)
- 6:10pm-6:20pm
Urinary Cell CTOT-04 Signature is Diagnostic of Glomerulitis in Kidney Allograft Biopsies
- 6:20pm-6:30pm
Association of Trugraf GEP with Clinical and Histological Outcomes in a Multicenter Cohort (TOGETHER Study)
- 6:30pm-6:40pm
Hepatocyte Notch1 Regulates Autophagy/DR5 Axis and Inhibits Cell Death in Mouse and Human Liver Transplantation
« View all sessions from the 2022 American Transplant Congress